Rising Cell Therapy Technology Market Demand from 2019-2028

Cell therapies offer the promise of treating and altering the course of diseases which cannot be addressed adequately by existing pharmaceuticals. It represents the most recent phase of the biotechnology revolution in medicine. As with many remedies, cell therapies are based on ground-breaking scientific discoveries and technology advancements. Furthermore, cell therapies are a diverse group across cell types and therapeutic indications and have been an active area of research for many years but are now strongly emerging through translation and towards successful commercial development and patient access. Moreover, the next generation of cell therapies now emerging are of diverse class. Cell therapies can be classified by the therapeutic indication they aim to address, e.g. neurological, cardiovascular, ophthalmological; by whether they comprise cells taken from and administered to the same individual (autologous) or derived from a donor (allogeneic); or most commonly by the cell types.

To know the scope of our report get a sample on https://www.axiommrc.com/request-for-sample/hc1908-cell-therapy-technology-market-report

CELL THERAPY TECHNOLOGY MARKET OUTLOOK

The large number of oncology-oriented cell-based therapy, advancements in technology and products are the factors driving the market growth. In addition, rising government investments in cell-based research is also expected to fuel the growth of cell therapy technology market. However, high cost of cell-based research & low success rate and lack of appropriate & advanced healthcare infrastructure in developing regions are some factors hampering the growth of the market.

CELL THERAPY TECHNOLOGY MARKET SEGMENTAL OVERVIEW

The cell therapy technology market is segmented by product, process, cell type, end user and geography

CELL THERAPY TECHNOLOGY MARKET BY PRODUCT

On the basis of product, the cell therapy technology market is segmented into consumables, equipment and systems & software. The equipment segment is further classified into cell processing equipment and single-use equipment. The cell therapy consumables market is driven by the factors such as increasing investments by companies to develop advanced products as well as government initiatives for enhancing cell-based research.

CELL THERAPY TECHNOLOGY MARKET BY PROCESS

On the basis of process, the cell therapy technology market is bifurcated into cell processing, cell preservation, distribution, & handling and process monitoring & quality control.  Especially during culture media processing, the cell processing stage makes the highest use of cell therapy instruments and media. Hence, the cell processing segment is on high demand.

CELL THERAPY TECHNOLOGY MARKET BY CELL TYPE

The cell types studied in this report are human cells and animal cells. The human cells segment is further classified into Stem Cells and differentiated Cells. In the last few years, stem cells therapy has been gaining traction worldwide. A significant rise in the number of clinical application of stem cells and the advent of new treatments for chronic diseases are estimated to enhance the growth of the stem cells segment in near future.

CELL THERAPY TECHNOLOGY MARKET BY END USER

The end user of the cell therapy technology market is segmented into life science research companies and research institutes.  The large share of life science research companies segment can be attributed to the high adoption of advanced instruments in cell-based experiments and cancer research as well as the increasing number of research & development facilities globally.

CELL THERAPY TECHNOLOGY MARKET BY GEOGRAPHY

Geographically, the global cell therapy technology market is diversified into North America, Europe, Asia-Pacific and rest of the world. The North America region dominated the cell therapy technology market in the 2018, owing to increasing R&D activities in the pharmaceutical and biotechnology industries in these region and high prevalence of chronic diseases. However, Asia Pacific is projected to emerge as the most promising region during the forecast period, due to the increasing research funding for vaccine development.

CELL THERAPY TECHNOLOGY MARKET KEY PLAYERS

The key companies operating in the market are Thermo Fisher Scientific, Inc., Merck KGaA, Terumo Bct, Inc. (A Subsidiary of Terumo Corporation), Lonza Group, Ge Healthcare, Sartorius, Becton, Dickinson and Company, Beckman Coulter, Inc. (Subsidiary of Danaher Corporation), Miltenyi Biotec GmbH and Stemcell Technologies. New product launches, mergers & acquisitions are the key strategies adopted by market players to ensure their growth in the market.

CELL THERAPY TECHNOLOGY MARKET RECENT DEVELOPMENTS

July 2018: Thermo Fisher Scientific launched a new series of compact refrigerators. It has been specifically developed to address the need of clinical laboratories and patient care facilities for cold storage equipment that enable secure and energy-efficient storage of vaccines, medicines, lab kits and breast milk, while offering quiet operation and a small footprint.

November 2018: Lonza Pharma & Biotech officially opens its Collaborative Innovation Center (CIC) in the Haifa Life Science Park, Israel. The CIC acts as a hub for partnerships to identify and accelerate new solutions for biopharma manufacturing.

April 2017: GE Healthcare has acquired Asymptote Limited. The acquisition of Asymptote fills a critical gap in GE Healthcare’s end-to-end ecosystem of products and services for cell therapy production, and will be an important piece of the portfolio enabling the industrialization of these life-saving therapies.

Buy now Cell Therapy Technology Market Report https://www.axiommrc.com/buy_now/hc1908-cell-therapy-technology-market-report

About Us:

Axiom Market Research & Consulting™ is a full-service market research and data analytics company providing key market intelligence to global companies to take informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc. 

Axiom Market Research & Consulting™ offers market research services such as syndicated market research, custom market research, business consulting, and consumer/end user surveys. Under Business to Consumer (B2C) market research offerings, Axiom MRC assists its clients in finding quantitative information/preferences of its brands and services such as, awareness, usages, satisfaction, tracking, ethnicity etc. Axiom MRC offers data collection services through online surveys, social media, data processing and interpretation.

Axiom MRC with its experienced team of research and data analysts, has delivered more than 5000+ Market Research Projects, 3800+ Data Analytics Projects, 1200+ Business Support Projects and has a 800+ Global Client Base. Axiom Market Research & Consulting™ aims to become the preferred market research and data analytics company by providing key market intelligence solutions for client’s business growth.

Contact Us:

Axiom Market Research & Consulting™

3 Germay Dr. Ste 4 - 4666

Wilmington DE 19804

U.S.:- + 1 (845) 875-9786

U.K.:- + 44 (0) 20 3286 9707

Email: sales@axiommrc.com

Website: https://www.axiommrc.com/

Blog: https://industrywatch24.com/

          https://readbeyondnews.com/

Follow On

LinkedIn: https://www.linkedin.com/company/axiom-market-research-and-consulting/

Twitter:  https://twitter.com/AxiommrcCom

Comments

Popular posts from this blog

Induced Pluripotent Stem Cells Market is anticipated to grow at a CAGR of 7.32% from 2022 to 2028

Viral Vector Manufacturing Market Insights, Trends, And Forecasts 2019-2028

Lubricants Market: Size, Segmentation, Key Players and Future Trends